多队列全血基因表达数据分析不能形成稳健的急性呼吸窘迫综合征诊断
该研究系统检索美国国立卫生研究院基因表达综合数据库和ArrayExpress中人类全血基因表达芯片数据,并纳入Glue Grant队列,比较研究者定义的48小时内ARDS与危重症对照。共纳入3个成人脓毒症队列、1个儿童急性呼吸衰竭队列和2个成人创伤与烧伤数据集,合计148例ARDS和268例危重症对照。识别出30个与ARDS显著相关基因(错误发现率<20%、效应量>1.3),但用临床严重度评分进行meta回归校正后无一保持显著。细胞类型富集分析显示条带和中性粒细胞富集,提示基因表达特征反映急性炎症而非肺损伤本身。最终构建的诊断基因集在留一数据集交叉验证中平均受试者工作特征曲线下面积仅0.63。
要点
- 多队列共148例ARDS与268例危重症对照的全血基因表达分析中,30个基因与ARDS显著相关(错误发现率<20%、效应量>1.3)。
- 用临床严重度评分进行meta回归校正后,30个基因无一保持显著,提示关联受疾病严重度混杂。
- 细胞类型富集显示条带和中性粒细胞富集,提示全血基因表达特征反映急性炎症而非肺损伤本身。
- 基于多队列优化的诊断基因集在留一数据集交叉验证中平均受试者工作特征曲线下面积仅0.63,不足以作为可推广诊断。
- 作者结论认为全血基因表达特征受全身炎症混杂,限制了其发现可推广ARDS诊断基因标签的效用。
适用人群与场景
- 研究者定义的ARDS(诊断后48小时内)成人及儿童患者,病因包括脓毒症、创伤、烧伤及儿童急性呼吸衰竭。
- 对照为相关危重症患者。
诊断标准与关键阈值
- ARDS由研究者定义,于诊断后48小时内纳入。
- 基因与ARDS显著关联的筛选标准为错误发现率<20%且效应量>1.3。
研究设计与关键结果
- 研究类型为多队列全血基因表达数据分析,数据来源为美国国立卫生研究院基因表达综合数据库、ArrayExpress及Glue Grant队列。
- 纳入3个成人脓毒症队列、1个儿童急性呼吸衰竭队列和2个成人创伤与烧伤数据集,合计148例ARDS和268例危重症对照。
- 识别出30个与ARDS显著相关基因(错误发现率<20%、效应量>1.3),其中许多此前与脓毒症相关。
- 用meta回归校正临床严重度评分后,30个基因无一保持显著。
- 细胞类型富集分析显示条带和中性粒细胞富集,提示基因表达特征为急性炎症而非肺损伤本身。
- 构建的通用诊断基因集在留一数据集交叉验证中平均受试者工作特征曲线下面积为0.63。
证据类型、等级与局限
- 证据类型:多队列基因表达数据分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论认为,跨广泛临床谱的ARDS全血基因表达特征可能受全身炎症混杂,限制了全血基因表达研究用于发现可推广诊断基因标签的效用。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To identify a novel, generalizable diagnostic for acute respiratory distress syndrome using whole-blood gene expression arrays from multiple acute respiratory distress syndrome cohorts of varying etiologies.
DATA SOURCES: We performed a systematic search for human whole-blood gene expression arrays of acute respiratory distress syndrome in National Institutes of Health Gene Expression Omnibus and ArrayExpress. We also included the Glue Grant gene expression cohorts.
STUDY SELECTION: We included investigator-defined acute respiratory distress syndrome within 48 hours of diagnosis and compared these with relevant critically ill controls.
DATA EXTRACTION: We used multicohort analysis of gene expression to identify genes significantly associated with acute respiratory distress syndrome, both with and without adjustment for clinical severity score. We performed gene ontology enrichment using Database for Annotation, Visualization and Integrated Discovery and cell type enrichment tests for both immune cells and pneumocyte gene expression. Finally, we selected a gene set optimized for diagnostic power across the datasets and used leave-one-dataset-out cross validation to assess robustness of the model.
DATA SYNTHESIS: We identified datasets from three adult cohorts with sepsis, one pediatric cohort with acute respiratory failure, and two datasets of adult patients with trauma and burns, for a total of 148 acute respiratory distress syndrome cases and 268 critically ill controls. We identified 30 genes that were significantly associated with acute respiratory distress syndrome (false discovery rate < 20% and effect size >1.3), many of which had been previously associated with sepsis. When metaregression was used to adjust for clinical severity scores, none of these genes remained significant. Cell type enrichment was notable for bands and neutrophils, suggesting that the gene expression signature is one of acute inflammation rather than lung injury per se. Finally, an attempt to develop a generalizable diagnostic gene set for acute respiratory distress syndrome showed a mean area under the receiver-operating characteristic curve of only 0.63 on leave-one-dataset-out cross validation.
CONCLUSIONS: The whole-blood gene expression signature across a wide clinical spectrum of acute respiratory distress syndrome is likely confounded by systemic inflammation, limiting the utility of whole-blood gene expression studies for uncovering a generalizable diagnostic gene signature.
参考来源
- Sweeney TE, Thomas NJ, Howrylak JA, et al. Multicohort Analysis of Whole-Blood Gene Expression Data Does Not Form a Robust Diagnostic for Acute Respiratory Distress Syndrome. Crit Care Med. 2018. PMID: 29337789. doi:10.1097/CCM.0000000000002839
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。